Study of Tipranavir and Ritonavir on the Pharmacokinetic Characteristics of Methadone Administered in Healthy Volunteers
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The primary objective of this study is to characterise the effects of tipranavir 500 mg and
ritonavir 200 mg (TPV/r; given twice daily) at steady-state on the pharmacokinetics of
methadone administered as a single dose in healthy adult volunteers